Galectin-3, osteopontin and successful aging

Sanchis-Gomar, F. ; Santos-Lozano, A. ; Pareja-Galeano, H. ; Garatachea, N. (Universidad de Zaragoza) ; Alis, R. ; Fiuza-Luces, C. ; Morán, M. ; Emanuele, E. ; Lucia, A.

Resumen: Background: Individuals who reach exceptional longevity (100+ years of age) free of common chronic age diseases (i.e. ''dodgers'') arguably represent the paradigm of successful aging in humans. As such, identification of potential biomarkers associated with this phenomenon is of medical interest. Methods: We measured serum levels of galectin-3 and osteopontin, both of which have been shown to be linked with major chronic or aging-related disorders in younger populations, in centenarian ''dodgers'' (n=81; 40 men; 100-104 years) and healthy controls (n=41; 24 men, 70-80 years). Results: Both biomarkers showed significantly lower values (p<0.001) in the former (galectin-3: 2.4±1.7 vs. 4.8±2.8 ng/mL; osteopontin: 38.1±27.7 vs. 72.6±33.1 µg/mL). Logistic regression analysis identified the combination of these two biomarkers as a significant predictor variable associated with successful aging regardless of sex (p<0.001). The area under the curve (AUC) classified the ability of galectin-3 and osteopontin to predict the likelihood of successful aging as ''fair'' (AUC=0.75) and ''good'' (AUC=0.80), respectively. Particularly, the combination of the two biomarkers showed good discriminatory power for successful aging (AUC=0.86), with sensitivity=83% and specificity=74%. Conclusions: Lower levels of both galectin-3 and osteopontin are associated with successful aging, representing potential biomarkers of this condition. Our cross-sectional data must be however approached with caution. Further research is necessary to replicate the present preliminary results in other cohorts and to identify the potential use of galectin-3 and osteopontin as potential targets (or at least predictors) in future personalized anti-aging therapies.

Idioma: Inglés

DOI: 10.1515/cclm-2015-0821

Año: 2016

Publicado en: Clinical Chemistry and Laboratory Medicine 54, 5 (2016), 873-877
ISSN: 1434-6621

Factor impacto JCR: 3.432 (2016)

Categ. JCR: MEDICAL LABORATORY TECHNOLOGY rank: 5 / 30 = 0.167 (2016) - Q1 - T1

Factor impacto SCIMAGO: 1.038 - Biochemistry (medical) (Q1) - Medicine (miscellaneous) (Q1) - Clinical Biochemistry (Q2)

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Educación Física y Depor. (Dpto. Fisiatría y Enfermería)